Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...
The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...
The current public-health risk is low, but the CDC is watching the situation carefully and working with states to monitor ...
The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the ...
Moderna receives $590M contract from HHS for mRNA-based bird flu vaccine; up 4% in after-hours trading. Read more here.
Given the uncertainty regarding its top-line growth, we would advise short-term investors to steer clear of MRNA stock.
The version of the virus spreading in North America right now has led to only a few serious cases, but concerns have been ...
Shares of Moderna (NASDAQ:MRNA) jumped 5% following reports that it had been awarded $590 million for the development of a ...
Moderna's been anything but a high-flying growth stock in this investor's portfolio. So is it high time he gave up on this ...
The U.S. Department of Health and Human Services or HHS said it will provide approximately $590 million to Moderna (MRNA) to ...
Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...